These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34636151)

  • 1. Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis.
    Suzuki E; Yashiro-Furuya M; Temmoku J; Fujita Y; Matsuoka N; Hazama M; Asano T; Sato S; Kobayashi H; Watanabe H; Kanno T; Migita K
    Int J Rheum Dis; 2021 Dec; 24(12):1500-1509. PubMed ID: 34636151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of renal relapse in Korean patients with lupus nephritis who achieved remission six months following induction therapy.
    Moon SJ; Park HS; Kwok SK; Ju JH; Choi BS; Park KS; Min JK; Kim HY; Park SH
    Lupus; 2013 Apr; 22(5):527-37. PubMed ID: 23423249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term renal survival of paediatric patients with lupus nephritis.
    Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
    Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time of initial appearance of renal symptoms in the course of systemic lupus erythematosus as a prognostic factor for lupus nephritis.
    Takahashi Y; Mizoue T; Suzuki A; Yamashita H; Kunimatsu J; Itoh K; Mimori A
    Mod Rheumatol; 2009; 19(3):293-301. PubMed ID: 19277827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan.
    Nakano M; Kubo K; Shirota Y; Iwasaki Y; Takahashi Y; Igari T; Inaba Y; Takeshima Y; Tateishi S; Yamashita H; Miyazaki M; Sato H; Kanda H; Kaneko H; Ishii T; Fujio K; Tanaka N; Mimori A
    Lupus; 2019 Aug; 28(9):1062-1073. PubMed ID: 31296139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
    Hailu GT; Hussen SU; Getachew S; Berha AB
    BMC Nephrol; 2022 Jun; 23(1):214. PubMed ID: 35715762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
    Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
    Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE.
    Gilbert M; Goilav B; Hsu JJ; Nietert PJ; Meidan E; Chua A; Ardoin SP; Wenderfer SE; von Scheven E; Ruth NM;
    Pediatr Rheumatol Online J; 2021 Aug; 19(1):137. PubMed ID: 34461932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort study.
    Ichinose K; Kitamura M; Sato S; Eguchi M; Okamoto M; Endo Y; Tsuji S; Takatani A; Shimizu T; Umeda M; Fukui S; Sumiyoshi R; Koga T; Kawashiri S; Iwamoto N; Igawa T; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
    Lupus; 2019 Apr; 28(4):501-509. PubMed ID: 30755146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment effectiveness and long-term prognosis of childhood-onset lupus nephritis].
    Cheng C; Wen SJ; Lin ZL; Jin B; Rong LP; Chen LZ; Mo Y; Jiang XY
    Zhonghua Er Ke Za Zhi; 2021 Sep; 59(9):730-736. PubMed ID: 34645212
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal relapse in children and adolescents with childhood-onset lupus nephritis: a 20-year study.
    Chan EY; Yap DY; Wong WH; Wong SW; Lin KY; Hui FY; Li JY; Lam SS; Wong JK; Lai FF; Ho TW; Tong PC; Lai WM; Chan TM; Ma AL
    Rheumatology (Oxford); 2024 Apr; 63(4):953-961. PubMed ID: 37632777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission and long-term outcomes of proliferative lupus nephritis: retrospective study of 96 patients from Saudi Arabia.
    Almalki AH; Alrowaie FA; Alhozali HM; Almalki NK; Alsubei AI; Alturki MS; Sadagah LF
    Lupus; 2019 Aug; 28(9):1082-1090. PubMed ID: 31296138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
    Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
    Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab as add-on therapy in patients with resistant lupus nephritis who have failed induction or maintenance therapy with other agents: A real-world experience from a single center in Mumbai.
    Yadav S; Balakrishnan C; Mangat G; Kothari J
    Lupus; 2024 Jan; 33(1):88-95. PubMed ID: 38048588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained remission of lupus nephritis.
    Barber CE; Geldenhuys L; Hanly JG
    Lupus; 2006; 15(2):94-101. PubMed ID: 16539280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
    Kwon OC; Park JH; Lee SW; Song JJ; Park YB; Park MC
    Yonsei Med J; 2020 Nov; 61(11):951-957. PubMed ID: 33107238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis.
    Zen M; Fuzzi E; Loredo Martinez M; Depascale R; Fredi M; Gatto M; Larosa M; Saccon F; Iaccarino L; Doria A
    Rheumatology (Oxford); 2022 Feb; 61(2):688-695. PubMed ID: 33909900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort.
    Ichinose K; Kitamura M; Sato S; Fujikawa K; Horai Y; Matsuoka N; Tsuboi M; Nonaka F; Shimizu T; Fukui S; Umeda M; Koga T; Kawashiri S; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
    Lupus; 2019 Mar; 28(3):295-303. PubMed ID: 30700214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
    Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS
    Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric lupus nephritis: more options, more chances?
    Vachvanichsanong P; McNeil E
    Lupus; 2013 May; 22(6):545-53. PubMed ID: 23629826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.